Site‐Selective Tyrosine Reaction for Antibody‐Cell Conjugation and Targeted Immunotherapy
Source abstract
Abstract
Abstract Targeted immunotherapies capitalize on the exceptional binding capabilities of antibodies to stimulate a host response that effectuates long‐lived tumor destruction. One example is the conjugation of immunoglobulins (IgGs) to immune effector cells, which equips the cells with the ability to recognize and accurately kill malignant cells through a process called antibody‐dependent cellular cytotoxicity (ADCC). In this study, a chemoenzymatic reaction is developed that specifically functionalizes a single tyrosine (Tyr, Y) residue, Y296, in the Fc domain of therapeutic IgGs. A one‐pot reaction that combines the tyrosinase‐catalyzed oxidation of tyrosine to o‐quinone with a subsequent [3+2] photoaddition with vinyl ether is employed. This reaction installs fluorescent molecules or bioorthogonal groups at Y296 of IgGs or the C‐terminal Y‐tag of an engineered nanobody. The Tyr‐specific reaction is utilized in constructing monofunctionalized antibody‐drug conjugates (ADCs) and antibody/nanobody‐conjugated effector cells, such as natural killer cells or macrophages. These results demonstrate the potential of site‐selective antibody reactions for enhancing targeted cancer immunotherapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Monoclonal and Polyclonal Antibodies Research · Click Chemistry and Applications · Synthesis and Biological Evaluation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry The Chinese University of Hong Kong Shatin Hong Kong SAR China
Funding
Chinese University of Hong Kong
References (80)
Show source-provided references
1. 10.3389/fmicb.2017.0049510.3389/fmicb.2017.00495 ↗
2. 10.1038/s43018-023-00516-z10.1038/s43018-023-00516-z ↗
3. 10.1038/s41392-021-00868-x10.1038/s41392-021-00868-x ↗
4. 10.1038/s41388-021-01811-810.1038/s41388-021-01811-8 ↗
5. 10.1038/nrc323610.1038/nrc3236 ↗
6. 10.1016/B978-0-12-394802-1.00001-710.1016/B978-0-12-394802-1.00001-7 ↗
7. 10.1016/B978-0-12-394802-1.00015-710.1016/B978-0-12-394802-1.00015-7 ↗
8. 10.1016/j.cell.2019.04.04110.1016/j.cell.2019.04.041 ↗
9. 10.3389/fimmu.2023.111330310.3389/fimmu.2023.1113303 ↗
10. 10.1038/s41571-020-0347-510.1038/s41571-020-0347-5 ↗
11. 10.1038/s41408-021-00459-710.1038/s41408-021-00459-7 ↗
12. 10.1038/s43018-021-00241-510.1038/s43018-021-00241-5 ↗
13. 10.1021/acscentsci.1c0126510.1021/acscentsci.1c01265 ↗
14. 10.1021/nn301047610.1021/nn3010476 ↗
15. 10.1016/j.actbio.2020.08.00810.1016/j.actbio.2020.08.008 ↗
16. 10.1016/j.jcyt.2020.01.00310.1016/j.jcyt.2020.01.003 ↗
17. 10.3390/cancers1311272410.3390/cancers13112724 ↗
18. 10.1002/anie.20220590210.1002/anie.202205902 ↗
19. 10.1021/acscentsci.8b0055210.1021/acscentsci.8b00552 ↗
20. 10.1002/anie.20090094210.1002/anie.200900942 ↗
21. 10.1021/cr500399p10.1021/cr500399p ↗
22. 10.1002/asia.20080042710.1002/asia.200800427 ↗
23. 10.1002/cbic.20150066710.1002/cbic.201500667 ↗
24. 10.1039/C7OB02844J10.1039/C7OB02844J ↗
25. 10.1021/jacs.6b0669210.1021/jacs.6b06692 ↗
26. 10.1038/s41586-018-0608-y10.1038/s41586-018-0608-y ↗
27. 10.1126/science.aal331610.1126/science.aal3316 ↗
28. 10.1002/chem.20200199210.1002/chem.202001992 ↗
29. 10.1002/anie.20130939910.1002/anie.201309399 ↗
30. 10.1002/anie.20141127710.1002/anie.201411277 ↗
31. 10.1016/0003-9861(59)90506-510.1016/0003-9861(59)90506-5 ↗
32. 10.1021/bc300410p10.1021/bc300410p ↗
33. 10.1016/j.bmcl.2008.12.07110.1016/j.bmcl.2008.12.071 ↗
34. 10.1039/C4CC07057G10.1039/C4CC07057G ↗
35. 10.1021/ja043901710.1021/ja0439017 ↗
36. 10.1021/ja710927q10.1021/ja710927q ↗
37. 10.1021/jo801738910.1021/jo8017389 ↗
38. 10.1128/JVI.03146-1210.1128/JVI.03146-12 ↗
39. 10.1039/D0OB01912G10.1039/D0OB01912G ↗
40. 10.1039/C4OB01873G10.1039/C4OB01873G ↗
41. 10.1039/c7pp00091j10.1039/c7pp00091j ↗
42. 10.1039/C5RA18271A10.1039/C5RA18271A ↗
43. 10.1021/jacs.8b0937210.1021/jacs.8b09372 ↗
44. 10.1039/C9SC02218J10.1039/C9SC02218J ↗
45. 10.1002/anie.20130383110.1002/anie.201303831 ↗
46. 10.1002/anie.20210228710.1002/anie.202102287 ↗
47. 10.1111/php.1216810.1111/php.12168 ↗
48. 10.1039/c9pp00182d10.1039/c9pp00182d ↗
49. 10.1021/ja503348d10.1021/ja503348d ↗
50. 10.1038/s41557-021-00733-y10.1038/s41557-021-00733-y ↗
51. 10.1042/bj222040710.1042/bj2220407 ↗
52. 10.1021/bc500534d10.1021/bc500534d ↗
53. 10.1002/adma.20140444810.1002/adma.201404448 ↗
54. 10.1002/anie.20100376110.1002/anie.201003761 ↗
55. 10.1021/acs.bioconjchem.7b0004610.1021/acs.bioconjchem.7b00046 ↗
56. 10.1021/acs.bioconjchem.8b0022710.1021/acs.bioconjchem.8b00227 ↗
57. 10.1021/jacs.9b1200210.1021/jacs.9b12002 ↗
58. 10.1021/jacs.5b1092810.1021/jacs.5b10928 ↗
59. 10.1246/cl.1989.910.1246/cl.1989.9 ↗
60. 10.1021/acscentsci.0c0094010.1021/acscentsci.0c00940 ↗
61. 10.1021/acscentsci.1c0126510.1021/acscentsci.1c01265 ↗
62. 10.1039/C8CC02638F10.1039/C8CC02638F ↗
63. 10.1021/acsomega.9b0172710.1021/acsomega.9b01727 ↗
64. 10.1016/j.str.2015.06.01510.1016/j.str.2015.06.015 ↗
65. 10.1021/acs.bioconjchem.1c0035110.1021/acs.bioconjchem.1c00351 ↗
66. 10.1021/jacs.8b0817510.1021/jacs.8b08175 ↗
67. 10.1021/acs.jpca.5b0797210.1021/acs.jpca.5b07972 ↗
68. 10.1021/jp068648710.1021/jp0686487 ↗
69. Makuraza J. · Int. J. Mater. Sci. Appl. · 2015 · 4 · 314
70. 10.1246/cl.1988.25110.1246/cl.1988.251 ↗
71. 10.1016/j.jphotochemrev.2017.10.00210.1016/j.jphotochemrev.2017.10.002 ↗
72. 10.1021/ar200059z10.1021/ar200059z ↗
73. 10.1186/s12929-019-0592-z10.1186/s12929-019-0592-z ↗
74. 10.1038/nbt114210.1038/nbt1142 ↗
75. 10.1038/nchem.241510.1038/nchem.2415 ↗
76. 10.1016/j.molmed.2016.12.00810.1016/j.molmed.2016.12.008 ↗
77. 10.1039/D2CS00446A10.1039/D2CS00446A ↗
78. 10.1002/anie.20190419310.1002/anie.201904193 ↗
79. 10.1002/anie.20220534810.1002/anie.202205348 ↗
80. 10.1039/C8CS00676H10.1039/C8CS00676H ↗